Breast Cancer Brachytherapy Market is anticipated to Exhibit Growth owing to Increasing Incidence of Breast Cancer
Breast Cancer Brachytherapy Market is anticipated to Exhibit Growth owing to Increasing Incidence of Breast Cancer
Blog Article
Breast cancer brachytherapy involves the insertion of radioactive sources directly into or near the breast tumor under image guidance. The procedure allows for delivery of high doses of radiation directly to tumors while limiting exposure of surrounding healthy tissues.
Brachytherapy delivers localized radiation directly to the tumor site and is commonly used as an alternative or addition to lumpectomy or mastectomy. Key advances in 3D image guided systems integration and optimized treatment planning software have expanded the applications of brachytherapy in early stage and accelerated partial breast irradiation.
The global breast cancer brachytherapy market is estimated to be valued at USD 961.1 Mn in 2025 and is expected to reach USD 1,544.3 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.0% from 2025 to 2032.
Key Takeaways
Key players operating in the breast cancer brachytherapy are Varian Medical Systems, Inc.,
Elekta AB, Eckert Ziegler BEBIG, iCAD, Inc., Hologic, Inc., Cianna Medical, IsoRay Medical, Inc., Theragenics Corporation, C.R. Bard, Inc., Boston Scientific Corporation, Merit Medical Systems, Cook Medical, SenoRx, Inc., Nucletron B.V., and Xoft, Inc.
Breast Cancer Brachytherapy Market size awareness regarding minimum invasive procedures and rising incidence of breast cancer worldwide presents significant growth opportunities for players in the market. Furthermore, technological advancements such as 3D image guided brachytherapy systems with integrated MRI/CT imaging and automated treatment planning have expanded the applications of brachytherapy in accelerated partial breast irradiation.
Technological developments aimed at improving treatment planning, precision and workflow efficiencies along with the broader indications for brachytherapy are expected to drive future demand.
Market Drivers
Rising global prevalence of breast cancer - According to WHO, breast cancer incidences have risen globally from an estimated 1.38 million in 2008 to 2.09 million annually in 2020. This growing cancer burden presents increasing demand for minimally invasive treatment approaches to brachytherapy. The need for alternative treatments to lumpectomy and mastectomy also drive adoption.
Advantages of brachytherapy over alternative surgeries - Brachytherapy offers faster recovery, better cosmetic outcomes and higher patient satisfaction levels as compared to mastectomy or wide-excision lumpectomy. These clinical advantages combined with comparable overall treatment efficacy have increased acceptance among oncologists and patients.
Current Challenges in Breast Cancer Brachytherapy Market
The breast cancer brachytherapy market is facing few challenges currently. Due to the complex nature of brachytherapy treatment planning, it requires experienced physicians as well as radiation oncologists to plan and perform the procedures which is challenging the market growth. Secondly, brachytherapy involves placing radioactive sources inside or close to the area requiring treatment. This raises safety concerns among patients and caregivers regarding exposure to radiation. The treatment also requires hospital stay ranging from few hours to few days based on prescribed dose which increases the overall treatment cost. Lastly, availability of alternative low cost treatment options like lumpectomy followed by external beam radiotherapy (EBRT) is limiting the market growth to some extent.
SWOT Analysis
Strength: Minimal damage to surrounding healthy tissues during treatment. Shorter treatment duration ranging from few hours to few days compared to other options.
Weakness: Requirement of highly skilled personnel for treatment planning and execution. Safety concerns regarding exposure to ionizing radiation.
Opportunity: Untapped developing regions with increasing cases of breast cancer. Recent technological advancements in applicator designs and delivery systems.
Threats: Presence of alternative low cost treatment options. Stringent regulatory policies regarding usage of radioactive sources.
North America Region Captures Largest Share in Breast Cancer Brachytherapy Market
North America is expected to account for the largest share in global breast cancer brachytherapy market during the forecast period. Factors such as increasing prevalence of breast cancer cases, improved accessibility to advanced treatment options and favorable healthcare reforms are driving the regional market growth. According to statistics, around 1 in 8 women in US are likely to develop breast cancer in their lifetime.
Asia Pacific Emerges as Fastest Growing Market
Factors such as expanding patient pool, rising healthcare spending, growing medical tourism industry and increasing awareness about novel treatment techniques are fueling the regional market growth. Countries like India, China and Japan are expected to provide immense opportunities for players operating in Asia Pacific breast cancer brachytherapy market.
Get More Insights On Breast Cancer Brachytherapy Market
Get this Report in Japanese Language
Get this Reports in Korean Language
About Author:
Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.
(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )
copyright src="chrome-extension://fpjppnhnpnknbenelmbnidjbolhandnf/content_script_web_accessible/ecp_aggressive.js" type="text/javascript"> Report this page